Single-use bioreactor utilizes disposable bag instead of reusable steel vessel used in conventional bioreactors. For industrial advantages, the single-use bioreactors are the more attractive options for multiproduct facilities with up to 6,000 liters. The use of single-use bioreactors is dependent on the criticality of the step, the value of the product produced, and the time taken for product development and production. The single-use bioreactor provides better flexibility, eliminates the need for sterilization, and incurs low operational cost without compromising the quality of the final product. This addresses the complexities associated with multidrug manufacturing processes while providing maximum savings on the time spent to prepare the bioreactor for the next batch. — Meticulous Research® in its latest publication on Single-use Bioreactor Market states that the global single-use bioreactor market will increase at a CAGR of 21.6% from 2019 to 2025 to reach $3.37 billion by 2025.
The growth of the single-use bioreactor market is mainly attributed to the adoption of disposable technology in the pharmaceutical and biotechnology industry, cost-effectiveness and lower downtime of single-use bioreactors and increasing government support for biopharmaceutical research. In addition, significant opportunities from emerging economies and growth in personalized medicine are expected to further encourage the growth of the market.
To provide efficient analysis, Meticulous Research® has segmented this market by product (single-use bioreactor systems, media bags, filtration assemblies, and other products), by molecule type (vaccines, monoclonal antibodies, stem cells, recombinant proteins, drugs, and others), type (stirred-tank, wave-induced, bubble-column, and others), cell type (mammalian, bacterial, yeast, and others), by application (bioproduction, research, and process development), usage (lab-scale, pilot-scale, large-scale), end-user (pharmaceutical & biotechnology company, contract research organizations research & academia), and geography (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa).
Make an enquiry of this Report @
Geographically, North America commanded the largest share of the global single-use bioreactors market is 2018, followed by Europe, Asia-Pacific, Latin America, and Middle East & Africa regions. However, Asia-Pacific is the fastest-growing regional market due to the accelerated economic growth of many countries in this region and increasing government focus on pharmaceutical research. In addition, government initiatives to escalate the drug development process, rising public and private funding for R&D activities, and rising contract research and manufacturing activities in the APAC region are propelling the growth of the Asia-Pacific single-use bioreactors market.
Based on cell type, mammalian cells commanded the largest share of the single-use bioreactor market in 2018. This is mainly attributed to proper protein folding, post-translational modifications, and product assembly, which play an important role to initiate complete biological activity in humans.
Based on usage, lab-scale production is the most common setting in which single-use bioreactors are preferably used. Lab-scale production commanded the largest share of the global single-use bioreactor market in 2018, owing to increasing research activities using single-use technologies. Benefits of single-use bioreactors in the form of ease of operation, limited sterilization requirements, and reduced chances of cross-contamination have led to greater preference for single-use technologies in lab-scale production.
Based on the application, bioproduction commanded the largest share of the global single-use bioreactor market. This is mainly attributed due to the growing demand for breakthrough therapies, increasing government funding, and growing research programs for biopharmaceuticals.
Key players of the Single-use Bioreactors Market
Thermo Fisher Scientific Inc.
Applikon Biotechnology B.V.
Solaris Biotechnology SRL
CESCO Bioengineering Co., Ltd.
PBS Biotech, Inc.
Pierre Guerin Technologies
Celltainer Biotech B.V.
Speak to our expert analyst @
Key questions answered in the report:
Pharmaceutical & biotechnology companies accounted for the largest share of the single-use bioreactor market, globally
Which geographic region is expected to experience the fastest growth in the usage of single-use bioreactors in pharmaceutical & biotechnology companies?
How does the penetration of single-use bioreactors in pharmaceutical & biotechnology companies differ from other end-users such as contract research organizations and research and academia?
Single-use bioreactor market favors both larger and local manufacturers that compete in multiple segments
Who are the top competitors in this market and what strategies do they employ to gain shares?
What is driving growth and which market segments have the most potential for revenue expansion over the forecast period?
What strategies should new companies look to enter this market use to compete effectively?
What are the major drivers, restraints, challenges, and opportunities in the single-use bioreactor market?
Who are the major players in various countries and what share of the market do they hold?
What are the geographical trends and high growth regions/ countries?
Recent partnerships, acquisitions, and expansions have taken place in the global single-use bioreactor market
Which companies have recently merged/acquired and how will these unions affect the competitive landscape of the single-use bioreactor market?
Which companies have created partnerships and how will these partnerships promote a competitive advantage?
Who are the major players in the global single-use bioreactor market and what share of the market do they hold?
What are the local emerging players in the global single-use bioreactor market and how do they compete with the global players?
Table of Contents
1.1. Market Ecosystem
1.2. Currency & Limitation
1.3. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.1.1. Secondary Research
2.1.2. Primary Research
2.1.3. Market Size Estimation
3. Executive Summary
4. Market Insights
4.2.1. Rapid Adoption of Disposable Technology in Pharmaceutical and Biotechnology Industry
4.2.2. Cost-Effectiveness and Lower Downtime of Single-use Bioreactor
4.2.3. Increase in Government Support for Biopharmaceutical Research
4.2.4. Growing Demand for Biopharmaceuticals
4.2.5. Frequent Launch of New Products
4.3.1. High Expenses Due to Recurrent Demand
4.3.2. Extractability and Leachability Issues Related to Disposable Components of Bioreactors
4.3.3. Stringent Regulatory Concerns associated with Single-use Bioreactor
4.4.1. Limited Culturing Capacity
4.5.1. Significant Opportunities from Emerging Economies
4.5.2. Personalized Medicine to Offer New Growth Potential
4.5.3. Expected Surge in Biosimilar Production in the U.S.
5. Single-use Bioreactor Market, by Product
5.2. Single-use Bioreactor systems
5.2.1. Upto 10L
5.2.5. Above 1500L
5.3. Media Bags
5.2.1. 2D Bags
5.2.2. 3D Bags
5.2.3. Other Bags
5.4. Filtration assemblies
6. Single-use Bioreactor Market, by Molecule Type
6.3. Monoclonal Antibodies
6.4. Stem Cells
6.5. Recombinant Proteins
7. Single-use Bioreactor Market, by Type
8. Single-use Bioreactor Market, by Cell type
8.2. Mammalian Cells
8.3. Bacterial Cells
8.4. Yeast Cells
9. Single-use Bioreactor Market, by Application
9.3. Research and Development (R&D)
9.4. Process Development
10. Single-use Bioreactor Market, by Usage
10.2. Lab-scale Production
10.3. Pilot-scale Production
10.4. Large-scale Production
To get valuable insights into the market, Download Sample Report @
Email: Send Email
Organization: Meticulous Market Research Pvt. Ltd.
Address: Pune, India
Release ID: 88942561